New approaches to treatment of ischemic heart disease: therapeutic angiogenesis in combination with surgical revascularization of the myocardium
Aim. To evaluate the results of surgical treatment of patients with ischemic heart disease in combination with intraoperative intramyocardial introduction of the human gene VEGF165 (angiostimulin). Material and methods. Twenty four patients enrolled in the study were examined using 12-lead ECG, echo...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2004-06-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/29816 |
id |
doaj-f1bb36108f4548b7bcca7364acefdf89 |
---|---|
record_format |
Article |
spelling |
doaj-f1bb36108f4548b7bcca7364acefdf892020-11-25T03:12:26Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422004-06-01796253026844New approaches to treatment of ischemic heart disease: therapeutic angiogenesis in combination with surgical revascularization of the myocardiumL A BockeriaE Z GolukhovaM V EremeevaS L KiselevI P AslanidiM N VakhromeevaA F KlyuevaE S PolyakovaM A LukashkinAim. To evaluate the results of surgical treatment of patients with ischemic heart disease in combination with intraoperative intramyocardial introduction of the human gene VEGF165 (angiostimulin). Material and methods. Twenty four patients enrolled in the study were examined using 12-lead ECG, echocardiography, treadmill exercise test, single-photon emission computed tomography of the myocardium with Tc-99m-tetrophosmine, fluorodesoxyglucose (FDG) positron-emission tomography of the myocardium, selective coronarography. Out of 24 patients, 10 patients have been reexamined so far. The effect of the treatment was assessed by the data obtained at the treadmill test, transthoracic echocardiography, myocardial scintigraphy and FDG. Results. All the patients demonstrated a clinical response. The class of effort angina improved, the dose of the prescribed nitric drugs was decreased, exercise tolerance and total stress time rose, quality of life improved. Myocardial scintigraphy registered reduction of the total area and better accumulation of the radiopharmaceutical under load and at rest 3 and 6 months after the operation including myocardial areas which had not been revacularised at coronary artery bypass grafting but had been treated with the preparation of the human gene VEGF165. Conclusion. The results of the study suggest that therapeutic angiogenesis may be an alternative impact on those myocardial areas which are suppled by the affected but ineligible for bypass grafting coronary arteries.https://ter-arkhiv.ru/0040-3660/article/view/29816ischemic heart diseasetherapeutic angiogenesissurgical revascularization |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
L A Bockeria E Z Golukhova M V Eremeeva S L Kiselev I P Aslanidi M N Vakhromeeva A F Klyueva E S Polyakova M A Lukashkin |
spellingShingle |
L A Bockeria E Z Golukhova M V Eremeeva S L Kiselev I P Aslanidi M N Vakhromeeva A F Klyueva E S Polyakova M A Lukashkin New approaches to treatment of ischemic heart disease: therapeutic angiogenesis in combination with surgical revascularization of the myocardium Терапевтический архив ischemic heart disease therapeutic angiogenesis surgical revascularization |
author_facet |
L A Bockeria E Z Golukhova M V Eremeeva S L Kiselev I P Aslanidi M N Vakhromeeva A F Klyueva E S Polyakova M A Lukashkin |
author_sort |
L A Bockeria |
title |
New approaches to treatment of ischemic heart disease: therapeutic angiogenesis in combination with surgical revascularization of the myocardium |
title_short |
New approaches to treatment of ischemic heart disease: therapeutic angiogenesis in combination with surgical revascularization of the myocardium |
title_full |
New approaches to treatment of ischemic heart disease: therapeutic angiogenesis in combination with surgical revascularization of the myocardium |
title_fullStr |
New approaches to treatment of ischemic heart disease: therapeutic angiogenesis in combination with surgical revascularization of the myocardium |
title_full_unstemmed |
New approaches to treatment of ischemic heart disease: therapeutic angiogenesis in combination with surgical revascularization of the myocardium |
title_sort |
new approaches to treatment of ischemic heart disease: therapeutic angiogenesis in combination with surgical revascularization of the myocardium |
publisher |
"Consilium Medicum" Publishing house |
series |
Терапевтический архив |
issn |
0040-3660 2309-5342 |
publishDate |
2004-06-01 |
description |
Aim. To evaluate the results of surgical treatment of patients with ischemic heart disease in combination with intraoperative intramyocardial introduction of the human gene VEGF165 (angiostimulin). Material and methods. Twenty four patients enrolled in the study were examined using 12-lead ECG, echocardiography, treadmill exercise test, single-photon emission computed tomography of the myocardium with Tc-99m-tetrophosmine, fluorodesoxyglucose (FDG) positron-emission tomography of the myocardium, selective coronarography. Out of 24 patients, 10 patients have been reexamined so far. The effect of the treatment was assessed by the data obtained at the treadmill test, transthoracic echocardiography, myocardial scintigraphy and FDG.
Results. All the patients demonstrated a clinical response. The class of effort angina improved, the dose of the prescribed nitric drugs was decreased, exercise tolerance and total stress time rose, quality of life improved. Myocardial scintigraphy registered reduction of the total area and better accumulation of the radiopharmaceutical under load and at rest 3 and 6 months after the operation including myocardial areas which had not been revacularised at coronary artery bypass grafting but had been treated with the preparation of the human gene VEGF165.
Conclusion. The results of the study suggest that therapeutic angiogenesis may be an alternative impact on those myocardial areas which are suppled by the affected but ineligible for bypass grafting coronary arteries. |
topic |
ischemic heart disease therapeutic angiogenesis surgical revascularization |
url |
https://ter-arkhiv.ru/0040-3660/article/view/29816 |
work_keys_str_mv |
AT labockeria newapproachestotreatmentofischemicheartdiseasetherapeuticangiogenesisincombinationwithsurgicalrevascularizationofthemyocardium AT ezgolukhova newapproachestotreatmentofischemicheartdiseasetherapeuticangiogenesisincombinationwithsurgicalrevascularizationofthemyocardium AT mveremeeva newapproachestotreatmentofischemicheartdiseasetherapeuticangiogenesisincombinationwithsurgicalrevascularizationofthemyocardium AT slkiselev newapproachestotreatmentofischemicheartdiseasetherapeuticangiogenesisincombinationwithsurgicalrevascularizationofthemyocardium AT ipaslanidi newapproachestotreatmentofischemicheartdiseasetherapeuticangiogenesisincombinationwithsurgicalrevascularizationofthemyocardium AT mnvakhromeeva newapproachestotreatmentofischemicheartdiseasetherapeuticangiogenesisincombinationwithsurgicalrevascularizationofthemyocardium AT afklyueva newapproachestotreatmentofischemicheartdiseasetherapeuticangiogenesisincombinationwithsurgicalrevascularizationofthemyocardium AT espolyakova newapproachestotreatmentofischemicheartdiseasetherapeuticangiogenesisincombinationwithsurgicalrevascularizationofthemyocardium AT malukashkin newapproachestotreatmentofischemicheartdiseasetherapeuticangiogenesisincombinationwithsurgicalrevascularizationofthemyocardium |
_version_ |
1724650302002429952 |